H-APYTFGQGTK^-OH

Ref. 3D-PP48866

Informations sur le produit

• Nom: H-APYTFGQGTK^-OH

Description

Peptide H-APYTFGQGTK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-APYTFGQGTK^-OH include the following: Qualification and application of a liquid chromatography-quadrupole time-of-flight mass spectrometric method for the determination of adalimumab in rat plasma Y Park, N Kim, J Choi, MH Park, BI Lee, SH Shin - Pharmaceutics, 2018 - mdpi.comhttps://www.mdpi.com/1999-4923/10/2/61 Qualification and Application of a Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometric Method for the Determination of Adalimumab in Rat Y Park , N Kim, J Choi, MH Park, B ill Lee - Drug Metabolism , 2020 - mdpi.comhttps://www.mdpi.com/books/pdfdownload/book/1337/1000#page=207 Comparison of Target-and IgG-Enrichment Strategies to Measure Adalimumab Concentrations in Human Plasma Using an Immunocapture-Liquid X Ding, S Zhu, L Liu, X Liu, K Zhu - Annals of Laboratory , 2024 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11169766/ Rapid and simultaneous quantification of a mixture of biopharmaceuticals by a liquid chromatography/quadrupole time-of-flight mass spectrometric method in rat MH Park, JJ Byeon, SH Shin, N Kim - Rapid , 2018 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.8123 Simultaneous quantification of free adalimumab and infliximab in human plasma using a target-based sample purification and liquid chromatography-tandem mass M El Amrani, SM Bosman, AC Egas - Therapeutic Drug , 2019 - journals.lww.comhttps://journals.lww.com/drug-monitoring/fulltext/2019/10000/Simultaneous_Quantification_of_Free_Adalimumab_and.14.aspx Simultaneous quantification of adalimumab and infliximab in human plasma by liquid chromatography-tandem mass spectrometry JF Jourdil, B Nemoz , E Gautier-Veyret - Therapeutic Drug , 2018 - journals.lww.comhttps://journals.lww.com/drug-monitoring/fulltext/2018/08000/simultaneous_quantification_of_adalimumab_and.7.aspx MSACL 2023 Abstract (s) for Tox/TDM/Endocrine J Halifax - msacl.orghttps://www.msacl.org/program/view_abstract_selection.php?topic=Tox+%2F+TDM+%2F+Endocrine&event=2023 Glutamine deamidation of a recombinant monoclonal antibody H Liu, G Gaza-Bulseco - Rapid Communications in , 2008 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.3831 MSACL 2023 Abstract (s) for Proteomics D Qasrawi - msacl.orghttps://www.msacl.org/program/view_abstract_selection.php?topic=Proteomics&event=2023 Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods C Tron, F Lemaitre , P Bros, C Goulvestre, B Franck - Bioanalysis, 2022 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/bio-2022-0057

• Marque: Biosynth